title: Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study.
authors.affiliation: Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University Medical Center, New York, NY, USA. jar2@columbia.edu
authors.forename: James A
authors.initials: JA
authors.lastname: Reiffel
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D053840:Brugada Syndrome / Q000139:chemically induced* / Q000175:diagnosis* / Q000503:physiopathology; D017115:Catheter Ablation; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D022062:Electrophysiologic Techniques, Cardiac; D005424:Flecainide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D005424:Flecainide; D011342:Procainamide